Clinical trial
Efficacy and Safety of Azimilide in the Prophylactic Treatment of Patients
NCT00035464 is registered in ClinicalTrials.gov with Forest Laboratories as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Azimilide in the Prophylactic Treatment of Patients
- Lead sponsor
- Forest Laboratories
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 31, 2000
- Completion date
- January 31, 2004
- Enrollment
- 431 (actual)
- Sites
- 103
Conditions
As the registry lists them; a condition with its own page is linked.